LDR First With Oblique ALIF Stand-Alone Cage (written by Walter Eisner @ OTW)
LDR has received clearance from the FDA to market the company's ROI-A Oblique ALIF Cage.
Christophe Lavigne, president and CEO of LDR, said in the November 1 press release that the clearance makes LDR the first company to introduce an oblique ALIF stand-alone cage into the U.S. market.
Reduces Need for Additional Instrumentation
The oblique cage complements its forerunner, the ROI-A ALIF cage, which is designed for direct anterior insertion. When used with the company’s integrated Vertebridge plating technology, both devices address the market for stand-alone lumbar fusion technology that reduces the need for additional anterior or posterior instrumentation. In addition to providing the benefits of ALIF surgery, a key feature of the ROI-A Oblique system, according to the company, is the opportunity to minimize the mobilization of the anterior vessels, without requiring the surgeon to consider a trans-psoatic lateral approach that may present increased neurologic risks and necessitate neuromonitoring.
Lavigne noted the company's recent approval in China to market both the ROI-A ALIF and ROI-C C...
